ZEB1 and pachyonychia congenita: To evaluate the translational potential of ZEB1 in PC chemoimmunotherapy, we selected mocetinostat, an epigenetic inhibitor of ZEB1, to assess its synergistic effect with chemoimmunotherapy in PC.